Table of Content




1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Incidence Of Neurovascular Conditions
3.1.2. Demand For Minimally Invasive Procedures
3.1.3. Significance Of Neurological Diseases In Geriatric Population
3.1.4. Prevalence Of Underlying Disease Conditions
3.2. Key Restraints
3.2.1. Exorbitant Cost Of Neurovascular Devices
3.2.2. Lack Of Adequate Number Of Trained Neurosurgeons

4. Key Analytics
4.1. Impact Of Covid-19 On Neurovascular Devices Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entry
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape

5. Market By Product
5.1. Embolization Devices
5.2. Accessory Devices
5.3. Revascularization Devices
5.4. Thrombectomy Devices
5.5. Embolic Protection Devices

6. Market By Application
6.1. Aneurysm
6.2. Ischemic Stroke
6.3. Stenosis
6.4. Arteriovenous Malformation (Avm)
6.5. Other Applications

7. Geographical Analysis
7.1. Asia-Pacific
7.1.1. Market Size & Estimates
7.1.2. Key Growth Enablers
7.1.3. Key Challenges
7.1.4. Key Players
7.1.5. Country Analysis
7.1.5.1. China
7.1.5.2. Japan
7.1.5.3. Australia & New Zealand
7.1.5.4. India
7.1.5.5. South Korea
7.1.5.6. Thailand
7.1.5.7. Indonesia
7.1.5.8. Vietnam
7.1.5.9. Rest Of Asia-Pacific

8. Competitive Landscape
8.1. Key Strategic Developments
8.1.1. Mergers & Acquisitions
8.1.2. Product Launches & Developments
8.1.3. Partnerships & Agreements
8.1.4. Business Expansions, Announcements & Divestitures
8.2. Company Profiles
8.2.1. Acandis Gmbh
8.2.2. Asahi Intecc
8.2.3. B Braun Melsungen Ag
8.2.4. Integer Holdings Corporation
8.2.5. Johnson & Johnson (Cerenovus)
8.2.6. Kaneka Corporation
8.2.7. Medtronic Inc
8.2.8. Memry Corporation
8.2.9. Microport Scientific Corporation
8.2.10. Penumbra Inc
8.2.11. Phenox Gmbh
8.2.12. Rapid Medical
8.2.13. Sensome
8.2.14. Stryker Corporation
8.2.15. Terumo Medical Corporation (Microvention Inc)



List of Figures


List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Asia-Pacific Neurovascular Devices Market, By Product, In 2020
Figure 6: Asia-Pacific Neurovascular Devices Market, By Embolization Devices, 2021-2028 (In $ Million)
Figure 7: Asia-Pacific Neurovascular Devices Market, By Accessory Devices, 2021-2028 (In $ Million)
Figure 8: Asia-Pacific Neurovascular Devices Market, By Revascularization Devices, 2021-2028 (In $ Million)
Figure 9: Asia-Pacific Neurovascular Devices Market, By Thrombectomy Devices, 2021-2028 (In $ Million)
Figure 10: Asia-Pacific Neurovascular Devices Market, By Embolic Protection Devices, 2021-2028 (In $ Million)
Figure 11: Asia-Pacific Neurovascular Devices Market, By Application, In 2020
Figure 12: Asia-Pacific Neurovascular Devices Market, By Aneurysm, 2021-2028 (In $ Million)
Figure 13: Asia-Pacific Neurovascular Devices Market, By Ischemic Stroke, 2021-2028 (In $ Million)
Figure 14: Asia-Pacific Neurovascular Devices Market, By Stenosis, 2021-2028 (In $ Million)
Figure 15: Asia-Pacific Neurovascular Devices Market, By Arteriovenous Malformation (Avm), 2021-2028 (In $ Million)
Figure 16: Asia-Pacific Neurovascular Devices Market, By Other Applications, 2021-2028 (In $ Million)
Figure 17: Asia-Pacific Neurovascular Devices Market, Country Outlook, 2020 & 2028 (In %)
Figure 18: China Neurovascular Devices Market, 2021-2028 (In $ Million)
Figure 19: Japan Neurovascular Devices Market, 2021-2028 (In $ Million)
Figure 20: Australia & New Zealand Neurovascular Devices Market, 2021-2028 (In $ Million)
Figure 21: India Neurovascular Devices Market, 2021-2028 (In $ Million)
Figure 22: South Korea Neurovascular Devices Market, 2021-2028 (In $ Million)
Figure 23: Thailand Neurovascular Devices Market, 2021-2028 (In $ Million)
Figure 24: Indonesia Neurovascular Devices Market, 2021-2028 (In $ Million)
Figure 25: Vietnam Neurovascular Devices Market, 2021-2028 (In $ Million)
Figure 26: Rest Of Asia-Pacific Neurovascular Devices Market, 2021-2028 (In $ Million)

List of Tables


LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - NEUROVASCULAR DEVICES
TABLE 2: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: LEADING PLAYERS OPERATING IN THE ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET
TABLE 9: LIST OF MERGERS & ACQUISITIONS
TABLE 10: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 11: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 12: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES